BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35807413)

  • 1. Canady Cold Helios Plasma Reduces Soft Tissue Sarcoma Viability by Inhibiting Proliferation, Disrupting Cell Cycle, and Inducing Apoptosis: A Preliminary Report.
    Ly L; Cheng X; Murthy SRK; Jones OZ; Zhuang T; Gitelis S; Blank AT; Nissan A; Adileh M; Colman M; Keidar M; Basadonna G; Canady J
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCL2A1 regulates Canady Helios Cold Plasma-induced cell death in triple-negative breast cancer.
    Murthy SRK; Cheng X; Zhuang T; Ly L; Jones O; Basadonna G; Keidar M; Canady J
    Sci Rep; 2022 Mar; 12(1):4038. PubMed ID: 35260587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canady Helios Cold Plasma Induces Breast Cancer Cell Death by Oxidation of Histone mRNA.
    Cheng X; Murthy SRK; Zhuang T; Ly L; Jones O; Basadonna G; Keidar M; Kanaan Y; Canady J
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The First Cold Atmospheric Plasma Phase I Clinical Trial for the Treatment of Advanced Solid Tumors: A Novel Treatment Arm for Cancer.
    Canady J; Murthy SRK; Zhuang T; Gitelis S; Nissan A; Ly L; Jones OZ; Cheng X; Adileh M; Blank AT; Colman MW; Millikan K; O'Donoghue C; Stenson KM; Ohara K; Schtrechman G; Keidar M; Basadonna G
    Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of proliferation and induction of apoptosis in soft tissue sarcoma cells by interferon-alpha and retinoids.
    Brodowicz T; Wiltschke C; Kandioler-Eckersberger D; Grunt TW; Rudas M; Schneider SM; Hejna M; Budinsky A; Zielinski CC
    Br J Cancer; 1999 Jul; 80(9):1350-8. PubMed ID: 10424735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti‑proliferative activity of epigallocatechin‑3‑gallate and silibinin on soft tissue sarcoma cells.
    Harati K; Behr B; Wallner C; Daigeler A; Hirsch T; Jacobsen F; Renner M; Harati A; Lehnhardt M; Becerikli M
    Mol Med Rep; 2017 Jan; 15(1):103-110. PubMed ID: 27909727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of TRAIL and taurolidine on apoptosis and proliferation in human rhabdomyosarcoma, leiomyosarcoma and epithelioid cell sarcoma.
    Karlisch C; Harati K; Chromik AM; Bulut D; Klein-Hitpass L; Goertz O; Hirsch T; Lehnhardt M; Uhl W; Daigeler A
    Int J Oncol; 2013 Mar; 42(3):945-56. PubMed ID: 23338823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trail-induced apoptosis and interaction with cytotoxic agents in soft tissue sarcoma cell lines.
    Tomek S; Koestler W; Horak P; Grunt T; Brodowicz T; Pribill I; Halaschek J; Haller G; Wiltschke C; Zielinski CC; Krainer M
    Eur J Cancer; 2003 Jun; 39(9):1318-29. PubMed ID: 12763223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of 1, 25-dihydroxyvitamin D3 on the growth of soft-tissue sarcoma cells as mediated by the vitamin D receptor.
    Shabahang M; Buffan AE; Nolla JM; Schumaker LM; Brenner RV; Buras RR; Nauta RJ; Evans SR
    Ann Surg Oncol; 1996 Mar; 3(2):144-9. PubMed ID: 8646514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Principles of treatment for soft tissue sarcoma.
    Dernell WS; Withrow SJ; Kuntz CA; Powers BE
    Clin Tech Small Anim Pract; 1998 Feb; 13(1):59-64. PubMed ID: 9634350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical patterns of soft-tissue sarcoma in children].
    Méndez R; Arnáiz S; Montero M; Tellado M; País E; Ríos J; Vela D
    Cir Pediatr; 2001 Jan; 14(1):14-20. PubMed ID: 11339112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soft tissue sarcoma of the upper extremity.
    Murray PM
    Hand Clin; 2004 Aug; 20(3):325-33, vii. PubMed ID: 15275691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043).
    Sleijfer S; Ray-Coquard I; Papai Z; Le Cesne A; Scurr M; Schöffski P; Collin F; Pandite L; Marreaud S; De Brauwer A; van Glabbeke M; Verweij J; Blay JY
    J Clin Oncol; 2009 Jul; 27(19):3126-32. PubMed ID: 19451427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Innovative Therapeutic Option for the Treatment of Skeletal Sarcomas: Elimination of Osteo- and Ewing's Sarcoma Cells Using Physical Gas Plasma.
    Jacoby JM; Strakeljahn S; Nitsch A; Bekeschus S; Hinz P; Mustea A; Ekkernkamp A; Tzvetkov MV; Haralambiev L; Stope MB
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32585948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synergistic effect of Canady Helios cold atmospheric plasma and a FOLFIRINOX regimen for the treatment of cholangiocarcinoma in vitro.
    Jones O; Cheng X; Murthy SRK; Ly L; Zhuang T; Basadonna G; Keidar M; Canady J
    Sci Rep; 2021 Apr; 11(1):8967. PubMed ID: 33903679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soft tissue sarcoma as a second malignant neoplasm in the pediatric age group.
    Bisogno G; Sotti G; Nowicki Y; Ferrari A; Garaventa A; Zanetti I; Favre C; Schiavetti A; Tamaro P; Carli M
    Cancer; 2004 Apr; 100(8):1758-65. PubMed ID: 15073867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.
    Karavasilis V; Seddon BM; Ashley S; Al-Muderis O; Fisher C; Judson I
    Cancer; 2008 Apr; 112(7):1585-91. PubMed ID: 18278813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological characteristics and prognostic factors of T1 (≤5 cm) soft tissue sarcoma -- a comparative study with T2 (>5 cm) soft tissue sarcoma.
    Kang S; Han I; Lee S; Kim W; Kim H
    Eur J Surg Oncol; 2014 Apr; 40(4):406-11. PubMed ID: 24388741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas.
    DuBois SG; Laetsch TW; Federman N; Turpin BK; Albert CM; Nagasubramanian R; Anderson ME; Davis JL; Qamoos HE; Reynolds ME; Cruickshank S; Cox MC; Hawkins DS; Mascarenhas L; Pappo AS
    Cancer; 2018 Nov; 124(21):4241-4247. PubMed ID: 30204247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soft tissue sarcoma brain metastases. Prevalence in a cohort of 3829 patients.
    Espat NJ; Bilsky M; Lewis JJ; Leung D; Brennan MF
    Cancer; 2002 May; 94(10):2706-11. PubMed ID: 12173340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.